[1] GUPTA A,DIXON E. Epidemiology and risk factors:Intrahepatic cholangiocarcinoma[J]. Hepatobiliary Surg Nutr,2017,6(2):101-104.
|
[2] SHAIB Y,EL-SERAG HB. The epidemiology of cholangiocarcinoma[J]. Semin Liver Dis,2004,24(2):115-125.
|
[3] WEBER SM,RIBERO D,O’REILLY EM,et al. Intrahepatic Cholangiocarcinoma:Expert consensus statement[J]. HPB,2015,17(8):669-680.
|
[4] ROBLES R,FIGUERAS J,TURRIN VS,et al. Spanish experience in liver transplantation for hilar and peripheral cholangiocarcinoma[J]. Ann Surg,2004,239(2):265-271.
|
[5] SOTIROPOULOS GC,KAISER GM,LANG H,et al. Liver transplantation as a primary indication for intrahepatic cholangiocarcinoma:A single-center experience[J]. Transplant Proc,2008,40(9):3194-3195.
|
[6] SAPISOCHIN G,FIDELMAN N,ROBERTS JP,et al. Mixed hepatocellular cholangiocarcinoma and intrahepatic cholangiocarcinoma in patients undergoing transplantation for hepatocellular carcinoma[J]. Liver Transpl,2011,17(8):934-942.
|
[7] PANJALA C,NGUYEN JH,AL-HAJJAJ AN,et al. Impact of neoadjuvant chemoradiation on the tumor burden before liver transplantation for unresectable cholangiocarcinoma[J]. Liver Transpl,2012,18(5):594-601.
|
[8] RAZUMILAVA N,GORES GJ. Cholangiocarcinoma[J]. Lancet,2014,383(9935):2168-2179.
|
[9] BRIDGEWATER J,GALLE PR,KHAN SA,et al. Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma[J]. J Hepatol,2014,60(6):1268-1289.
|
[10] SAPISOCHIN G,de LOPE CR,GASTACA M,et al. Intrahepatic cholangiocarcinoma or mixed hepatocellular-cholangiocarcinoma in patients undergoing liver transplantation:A Spanish matched cohort multicenter study[J]. Ann Surg,2014,259(5):944-952.
|
[11] SAPISOCHIN G,RODRGUEZ de LOPE C,GASTACA M,et al.“Very early”intrahepatic cholangiocarcinoma in cirrhotic patients:Should liver transplantation be reconsidered in these patients?[J]. Am J Transplant,2014,14(3):660-667.
|
[12] SAPISOCHIN G,FACCIUTO M,RUBBIA-BRANDT L,et al.Liver transplantation for"very early"intrahepatic cholangiocarcinoma:International retrospective study supporting a prospective assessment[J]. Hepatology,2016,64(4):1178-1188.
|
[13] HONG JC,JONES CM,DUFFY JP,et al. Comparative analysis of resection and liver transplantation for intrahepatic and hilar cholangiocarcinoma:A 24-year experience in a single center[J]. Arch Surg,2011,146:683-689.
|
[14] HONG JC,KALDAS FM,KOSITAMONGKOL P,et al. Predictive index for long-term survival after retransplantation of the liver in adult recipients:Analysis of a 26-year experience in a single center[J]. Ann Surg,2011,254(3):444-448; discussion 448-449.
|
[15] FACCIUTO ME,SINGH MK,LUBEZKY N,et al. Tumors with intrahepatic bile duct differentiation in cirrhosis:Implications on outcomes after liver transplantation[J]. Transplantation,2015,99(1):151-157.
|
[16] NJEI B,SCHILSKY ML,DITAH IC,et al. Should liver transplantation be reconsidered in patients with intrahepatic cholangiocarcinoma? A systematic review and meta-regression analysis of epidemiologic evidence[J]. Gastroenterology,2015,148(4):S-1036.
|
[17] GOLDSTEIN RM,STONE M,TILLERY GW,et al. Is liver transplantation indicated for cholangiocarcinoma?[J]. Am J Surg,1993,166(6):768-771; discussion 771-772.
|
[18] CARRAFIELLO G,LAGAND,COTTA E,et al. Radiofrequency ablation of intrahepatic cholangiocarcinoma:Preliminary experience[J]. Cardiovasc Intervent Radiol,2010,33(4):835-839.
|
[19] TSE RV,HAWKINS M,LOCKWOOD G,et al. Phase I study of individualized stereotactic body radiotherapy for hepatocellular carcinoma and intrahepatic cholangiocarcinoma[J]. J Clin Oncol,2008,26(4):657-664.
|
[20] KOPEK N,HOLT MI,HANSEN AT,et al. Stereotactic body radiotherapy for unresectable cholangiocarcinoma[J]. Radiother Oncol,2010,94(1):47-52.
|
[21] ZHOU L,DU GS,ZHU ZD,et al. Report on the efficacy of triple therapy in the prevention of recurrence after liver transplantation for advanced intrahepatic cholangiocarcinoma[J/CD].Chin J Oper Proc Gen Surg:Electronic Version,2014,8(1):39-41.(in Chinese)周林,杜国盛,朱志东,等.预防晚期肝内胆管细胞癌肝移植术后复发的三联疗法疗效报道[J/CD].中华普外科手术学杂志:电子版,2014,8(1):39-41.
|